About Cardeon
Cardeon is a venture capital firm founded in 2018. It is primarily based out of Lund, Sweden. As of Mar 2020, Cardeon has invested in 9 companies. It primarily invests in Seed round in Sweden based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and Healthcare. Most recently it participated in the $***** Seed round of Reccan Diagnostics A lot of funds co-invest with Cardeon, with names like Christer Fåhraeus sharing a substantial percentage of its portfolio. Cardeon has team of 5 people including 5 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed
Cardeon's List of Top Investments
Cardeon has a portfolio of 9 companies. Their most notable investmentis in Reccan DiagnosticsTheir portfolio spans across Sweden and Switzerland. They have invested in Life Sciences, Enterprise Applications, Healthcare, across Seed stage. Here is the list of top investments by Cardeon:1. Elicera
Elicera Therapeutics develops therapeutics, oncolytic virus and CAR-T cell-based therapies to treat cancer. The company has developed a platform technology called iTANK (ImmunoTherapies Activated with Nap for efficient Killing) to optimize the drugs. The company has developed oncolytic virus AdVince (ELC-100) is a oncolytic genetically modified adenovirus (Ad5PTD) for killing neuroendocrine cancer cells (phase I/II-study) and CAR T-cell therapy ELC-301 for the treatment of Non-Hodgkin's B-cell lymphoma (phase I/II-study).
Key facts about Elicera
2. Cellestia
Developer of small molecule cancer therapeutics targeting NOTCH pathway. The company's lead candidate, CB-103 is a first-in-class, oral pan-NOTCH inhibitor for the treatment of NOTCH-dependent leukemias, lymphomas, and solid tumors. The company is also developing NOTCH-specific biomarkers for patient selection.
Key facts about Cellestia
- Founded Year: 2014
- Location: Basel (Switzerland)
- Stage: Series C
- Total Funding till date: $48.5M
- Employee Count: 22 as on Jul 01, 2024
- Investors: PPF Group, Shield Investment and 10 Others
- Latest Funding Round: Series C, Aug 17, 2021, $*****
- Highlight: Editors' Pick
Reccan Diagnostics develops a platform for in vitro diagnostics. Their technology helps in early and specific diagnosis, prognosis and prediction of solid cancers. Their technology is based on a patented combination of protein biomarkers detectable in blood samples. The company has its primary focus area in pancreatic cancer.
Key facts about Reccan Diagnostics
- Founded Year: 2015
- Location: Lund (Sweden)
- Stage: Seed
- Total Funding till date: $1.54M
- Investors: Faro Capital, Cardeon and 2 Others
- Latest Funding Round: Seed, Mar 18, 2020, $*****
- Highlight: Editors' Pick
4. NeoDynamics
Provider of a medical device for screening breast cancer. The company's product includes NeoNavia which is a biopsy system, used for the imaging and screening of breast cancer. The company has developed a patented platform called micro-pulse technology that is used for the insertion of a vacuum-assisted biopsy needle (VAB) through healthy tissue for the placement of it in the lesion.
Key facts about NeoDynamics
- Founded Year: 2020
- Location: Lidingo (Sweden)
- Stage: Funding Raised
- Employee Count: 1 - 10 as on Jul 01, 2024
- Investors: Keiretsu Forum Nordics and Cardeon
- Highlight: Editors' Pick
5. SpectraCure
SpectraCure is developing an interstitial photodynamic therapy for solid tumors (prostate and pancreas, as well as ENT). The treatment involves the administration of a photosensitizing drug and a non-thermal laser light under the management of a new dosimetry approach. They have proprietary software, iDOSE, for safe interstitial PDT treatment. iDOSE allows for 3D image-based treatment planning using advanced dose-planning tools to control light exposure.
Key facts about SpectraCure
Cardeon's Year-on-Year Investment Trends
Its most recent first time investment was in Reccan Diagnostics.Cardeon's Investments by Stage
Cardeon has made 1 investment in Seed stage with an average round size of $1.54M.Cardeon's Investments by Sector
Cardeon has a portfolio focused on Life Sciences. Notably, it has invested in 8 Enterprise (B2B) companies, 8 Tech companies, 4 Tech hardware companies and 2 companies focusing on Software.Cardeon's Investments by Geography
Cardeon has made most investments in Sweden (1).Cardeon's recent investments
Cardeon has not made any investment in 2026 so far.Here are the most recent investments by Cardeon:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 18, 2020 | Sweden | Seed | 3768 | [+1] |
Team profile of Cardeon
Cardeon has a team of 5 members including 5 Partners located in Sweden. Cardeon's team does not sit on the board of any company as of now.Here is a list of all team members in Cardeon:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Lund | - | ||
Partner | - | - | ||
Partner | Stockholm | - | ||
Partner | - | - | - | |
Partner | - | - |
Co-investors of Cardeon
Over the past 6 years, 2 investors have co-invested in Cardeon's portfolio companies. This includes funds and angels.
- Top Co-investors of Cardeon: 2 investors entered a company along with Cardeon. These include investors like Christer Fåhraeus (1 company).
Recent News related to Cardeon
•
